INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE COTE D'AZUR FILES APPLICATION FOR "INHIBITOR OF RAB30 FOR USE IN A METHOD OF TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)"

GENEVA, March 23 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, Rue Michel Ange75016 Paris), UNIVERSITE COTE D'AZUR (Grand Chateau 28, Avenue de Valrose06103 NICE) filed a patent application (PCT/EP2025/075853) for "INHIBITOR OF RAB30 FOR USE IN A METHOD OF TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)" on Sep 11, 2025. With publication no. WO/2026/057679, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inve...